Canadian government officials are expected to provide an update on the AstraZeneca COVID-19 vaccine on Wednesday.

The update comes a day after Canada announced its first report of a rare blood clot in a person who received the AstraZeneca COVID-19 vaccine. The Public Health Agency of Canada (PHAC) and the Quebec health ministry said the female patient, whose age was not revealed, is recovering at home.

“Reports of blood clots with low platelets in people vaccinated with the AstraZeneca COVID-19 vaccine are very rare and the report of this case shows that Canada’s vaccine safety monitoring system works,” PHAC said in a statement.

The vaccine was produced at the Serum Institute of India and is known as CoviShield. The institute is manufacturing its own version of the vaccine under license — and its Canadian partner Verity Pharmaceuticals.

It also comes after the U.S. paused the use of the Johnson & Johnson COVID-19 vaccine. Prime Minister Justin Trudeau said Tuesday they were still on track to get doses of the vaccine but were monitoring the situation regarding the pause in the U.S.

MORE: https://globalnews.ca/news/7755376/astrazeneca-covid-19-vaccine-blood-clot/

For more info, please go to http://www.globalnews.ca
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Canada #COVID #Coronavirus #GlobalNews